Purpose Methamphetamine (METH) abuse is a serious concern in the United States, but no approved therapeutics are available to treat addicted individuals. Meth increases extracellular dopamine in reward-relevant dopamine pathways by interacting at the vesicular monoamine transporter-2 (VMAT2). Lobeline, the major alkaloid in Lobelia inflata, potently inhibited methamphetamine-evoked dopamine release from striatal slices and attenuated meth self-administration in rats. Improved water solubility and enhanced drug-likeness was afforded by the synthesis of GZ-793A, which similarly inhibited the neurochemical and behavioral effects of methamphetamine without the development of tolerance.
